Search

everythinglearnresearchcommunity

for

Search:↓

The combination therapy improved hair growth and thickness in people with androgenetic alopecia.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Analog 23 is a promising compound for prostate cancer treatment.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Adriamycin and ifosfamide together work best for advanced soft tissue sarcomas.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Skin patting and iontophoresis with dutasteride gel improved hair growth in people with androgenetic alopecia.

AA–TF#15 significantly promotes hair regrowth and could be an effective treatment for androgenic alopecia.

Dutasteride improved both hair loss and acne in two young men.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

Oral minoxidil can help regrow hair lost from antibody-drug conjugate treatment.

The removal of the adrenal tumor improved the patient's symptoms and reduced androgen levels, indicating successful surgery.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

AH-001 could be a safer and more effective treatment for hair loss.

Using 5α-reductase inhibitors for hair loss in women doesn't increase cancer risk.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Cyproterone acetate improves skin symptoms and quality of life in women with androgen-related issues.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

5ARI treatment improves PSA test accuracy for prostate cancer diagnosis.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Dutasteride mesotherapy for hair loss can cause lasting bald patches.

Tamoxifen may cause female hair loss by increasing androgen receptor expression.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Ayurveda-based care with Guduchi, Ashwagandha, and Curcumin improved quality of life for breast cancer patients without serious side effects.

Antiandrogens can help treat female pattern hair loss.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.